Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-03

Clinical Trial Update: Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375) [Phase 3]

View source ↗

Summary

Phase 3 trial update for ramelteon (TAK 375) in elderly patients with insomnia and obstructive sleep apnea has completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ramelteon (ramelteon)

Snippet

Sponsor: University of Pennsylvania | Conditions: Insomnia, Obstructive Sleep Apnea | Phase 3 | Status: COMPLETED | Results posted: 2017-05-03